<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[marketing and pharmaceutical company Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/marketing+and+pharmaceutical+company.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to marketing and pharmaceutical company]]></description>
	<s:counts start="0" returned="20" found="68" />
	<language>en-us</language>
	<item>
		<title><![CDATA[WebMD HLTH Corporation Q3 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14061_23-360511.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator Operator Instructions.  Our first question comes from Mark Mahaney with Citigroup. Mark Mahaney &#8211; Citigroup On the materiality on both the UK launch and the pets vertical, the pets offering, anyway to help us think about how big that can be, what kind of margin...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Tue, 03 Nov 2009 20:41:08 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/channel.html"><![CDATA[Channel]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/webmd.html"><![CDATA[WebMD]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/marketing+research.html"><![CDATA[Marketing Research]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/hlth+corp..html"><![CDATA[HLTH Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">HLTH</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">WBMD</category>
		<category domain="tickers">HLTH,WBMD</category>
	</item>
	<item>
		<title><![CDATA[Emerging market for medicines]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fwww.ft.com%2Fcms%2Fs%2F0%2F4d3e7cd6-808e-11de-bf04-00144feabdc0.html&siteid=23&tag=financialtimes]]></link>
		<description><![CDATA[ When Haruo Naito, chief executive of Eisai, the Japanese pharmaceutical company, signalled his continued interest in western markets by inaugurating his company's European headquarters in the UK last month, his mind was already elsewhere."We have already finished our investments in all major areas in the US and Europe," he...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Mon, 03 Aug 2009 19:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/india.html"><![CDATA[India]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/emerging+market.html"><![CDATA[Emerging Market]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/marketing+research.html"><![CDATA[Marketing Research]]></category>
		<category domain="http://resources.bnet.com/topic/financial+services.html"><![CDATA[Financial Services]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/company+news.html"><![CDATA[Company News]]></category>
		<category domain="http://resources.bnet.com/topic/financial+times.html"><![CDATA[Financial Times]]></category>
	</item>
	<item>
		<title><![CDATA[WebMD Health Corporation Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14052_23-326932.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Thank you, sir. Operator Instructions Our first question comes from Mark Mahaney from Citigroup. Please go ahead. Mark Mahaney &#8211; Citigroup  Great. Thank you. I wanted to ask a question about some of the impact on your business on customer demand from some of the regulatory...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Thu, 30 Jul 2009 18:26:12 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/advertisement.html"><![CDATA[Advertisement]]></category>
		<category domain="http://resources.bnet.com/topic/brand.html"><![CDATA[Brand]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/webmd+health+corp..html"><![CDATA[WebMD Health Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/branding.html"><![CDATA[Branding]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/webmd.html"><![CDATA[WebMD]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">WBMD</category>
		<category domain="tickers">WBMD</category>
	</item>
	<item>
		<title><![CDATA[NPR Producer: Goodwin Broke "Ironclad" Contract Over GSK Cash; Pitts Didn't Disclose Ties]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001303/npr-producer-goodwin-broke-ironclad-contract-over-gsk-cash-pitts-didnt-disclose-ties/]]></link>
		<description><![CDATA[The producer of an NPR radio show has accused the show's host, Fred Goodwin, of breaking his contract by failing to disclose his ties to drug companies.    The producer also denies that Peter Pitts, a former FDA official and an executive at Manning, Selvage & Lee, a...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 09 Mar 2009 06:40:11 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/drug+company.html"><![CDATA[Drug Company]]></category>
		<category domain="http://resources.bnet.com/topic/npr.html"><![CDATA[NPR]]></category>
		<category domain="http://resources.bnet.com/topic/radio.html"><![CDATA[Radio]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/tie.html"><![CDATA[Tie]]></category>
		<category domain="http://resources.bnet.com/topic/satellite+radio.html"><![CDATA[Satellite Radio]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/advertising+%2526+promotion.html"><![CDATA[Advertising & Promotion]]></category>
		<category domain="http://resources.bnet.com/topic/public+relations.html"><![CDATA[Public Relations]]></category>
		<category domain="http://resources.bnet.com/topic/consumer+electronics.html"><![CDATA[Consumer Electronics]]></category>
		<category domain="http://resources.bnet.com/topic/personal+technology.html"><![CDATA[Personal Technology]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+communications.html"><![CDATA[Corporate Communications]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Novartis, Boehringer Start Using Twitter Accounts]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001062/novartis-boehringer-start-using-twitter-accounts/]]></link>
		<description><![CDATA[AstraZeneca, Novartis, Vertex Pharmaceuticals and Boehringer Ingelheim have started experimenting with Twitter with varying degrees of enthusiasm, reports Pharmaceutical Executive.    Drug companies have so far looked at social media with a mixture of fear and loathing. They believe perhaps wrongly that giving consumers more opportunities to talk...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 18 Feb 2009 10:02:53 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/drug+company.html"><![CDATA[Drug Company]]></category>
		<category domain="http://resources.bnet.com/topic/social+media.html"><![CDATA[Social Media]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/twitter.html"><![CDATA[Twitter]]></category>
		<category domain="http://resources.bnet.com/topic/az.html"><![CDATA[AZ]]></category>
		<category domain="http://resources.bnet.com/topic/bi+site.html"><![CDATA[BI Site]]></category>
		<category domain="http://resources.bnet.com/topic/pricing.html"><![CDATA[Pricing]]></category>
		<category domain="http://resources.bnet.com/topic/business+intelligence.html"><![CDATA[Business Intelligence]]></category>
		<category domain="http://resources.bnet.com/topic/tools+%2526+techniques.html"><![CDATA[Tools & Techniques]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/data+management.html"><![CDATA[Data Management]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">NVS</category>
	</item>
	<item>
		<title><![CDATA[Will P&G Pharma Auction End the Company's Pursuit of "Viagra for Women"?]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000491/will-pg-pharma-auction-end-the-companys-pursuit-of-viagra-for-women/]]></link>
		<description><![CDATA[Procter & Gamble's desire to get out of the prescription pharmaceutical business either by selling its brands or managing them through their natural declines raises the question of whether this will finally kill P&G's longtime, ill-fated interest in creating a version of Viagra for women. BNET readers will remember that...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 11 Dec 2008 14:31:36 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/brand.html"><![CDATA[Brand]]></category>
		<category domain="http://resources.bnet.com/topic/women.html"><![CDATA[Women]]></category>
		<category domain="http://resources.bnet.com/topic/procter+%2526+gamble+co..html"><![CDATA[Procter & Gamble Co.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/auction.html"><![CDATA[Auction]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/noven.html"><![CDATA[Noven]]></category>
		<category domain="http://resources.bnet.com/topic/zestra.html"><![CDATA[Zestra]]></category>
		<category domain="http://resources.bnet.com/topic/gender+and+diversity.html"><![CDATA[Gender And Diversity]]></category>
		<category domain="http://resources.bnet.com/topic/branding.html"><![CDATA[Branding]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PG</category>
		<category domain="tickers">PG</category>
	</item>
	<item>
		<title><![CDATA[Pharma Roundup: AstraZeneca's Crestor Success, Pfizer's Chantix Problems, and More]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000377/pharma-roundup-astrazenecas-crestor-success-pfizers-chantix-problems-and-more/]]></link>
		<description><![CDATA[Highly encouraging results on AZ's Crestor, UK drug regulators echo Chantix suicide concerns, OTC drug marketers struggle, Lilly CEO highlights three "gorillas" dogging pharma. by John Maas]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 10 Nov 2008 16:47:57 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/brand.html"><![CDATA[Brand]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/gorilla.html"><![CDATA[Gorilla]]></category>
		<category domain="http://resources.bnet.com/topic/branding.html"><![CDATA[Branding]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">AZN,PFE</category>
	</item>
	<item>
		<title><![CDATA[Pharma Roundup: Schering-Plough Surveys Investors, Wyeth Defended, and More]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000351/pharma-roundup-schering-plough-surveys-investors-wyeth-defended-and-more/]]></link>
		<description><![CDATA[Schering-Plough shareholders to have say on executive compensation, U.S. drug sales predictions lowered, McCain and Obama both promise hard line on Big Pharma. Also: two lawyers condemn unfounded anti-Wyeth opinions. by John Maas]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 29 Oct 2008 17:25:56 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/wyeth.html"><![CDATA[Wyeth]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/schering-plough+corp..html"><![CDATA[Schering-Plough Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/survey.html"><![CDATA[Survey]]></category>
		<category domain="http://resources.bnet.com/topic/investor.html"><![CDATA[Investor]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://resources.bnet.com/topic/wyeth.html"><![CDATA[Wyeth]]></category>
		<category domain="http://resources.bnet.com/topic/drug+company.html"><![CDATA[Drug Company]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/schering-plough+corp..html"><![CDATA[Schering-Plough Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/survey.html"><![CDATA[Survey]]></category>
		<category domain="http://resources.bnet.com/topic/investor.html"><![CDATA[Investor]]></category>
		<category domain="http://resources.bnet.com/topic/marketing+research.html"><![CDATA[Marketing Research]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SGP</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">WYE</category>
		<category domain="tickers">SGP,WYE</category>
	</item>
	<item>
		<title><![CDATA[Pharma Roundup: Wyeth Slimming Distribution Network, Pfizer Suppressed Study, and More]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000271/pharma-roundup-wyeth-slimming-distribution-network-pfizer-suppressed-study-and-more/]]></link>
		<description><![CDATA[Wyeth eliminates East Coast distributor; Pfizer suppressed Neurontin study; entrepreneur urges rescue of U.K. biotech industry; pharma companies now contributing to McCain. by John Maas]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 08 Oct 2008 15:42:25 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/wyeth.html"><![CDATA[Wyeth]]></category>
		<category domain="http://resources.bnet.com/topic/network.html"><![CDATA[Network]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/marketing+research.html"><![CDATA[Marketing Research]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">WYE</category>
		<category domain="tickers">PFE,WYE</category>
	</item>
	<item>
		<title><![CDATA[Corporate Espionage Allegations Reveal Storm in a Teacup at Pharma Conference]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000233/corporate-espionage-allegations-reveal-storm-in-a-teacup-at-pharma-conference/]]></link>
		<description><![CDATA[There was a behind-the-scenes drama at the Pharma Competitive Intelligence conference in New Jersey last week involving allegations that the organizer of the conference engaged in "misappropriation of company assets" and that subpoenas have been sent to Pfizer, Johnson & Johnson, Sanofi-Aventis, Merck, Novartis, and Bristol-Myers Squibb.   ...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 23 Sep 2008 09:08:07 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/conference.html"><![CDATA[Conference]]></category>
		<category domain="http://resources.bnet.com/topic/tools+%2526+techniques.html"><![CDATA[Tools & Techniques]]></category>
		<category domain="http://resources.bnet.com/topic/marketing+research.html"><![CDATA[Marketing Research]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[The Incredible Shrinking Pharma Industry]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000146/the-incredible-shrinking-pharma-industry/]]></link>
		<description><![CDATA[It's not just layoffs anymore. The market-research firm Industrial Info Resources notes in a recent report that pharma plans to shutter 26 plants and research facilities across North America, in addition to the tens of thousands of sales reps, scientists and manufacturing-plant workers big drugmakers are letting go. Those closures...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Sun, 27 Jul 2008 20:26:14 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/blockbuster.html"><![CDATA[Blockbuster]]></category>
		<category domain="http://resources.bnet.com/topic/david+p.+hamilton.html"><![CDATA[David P. Hamilton]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
	</item>
	<item>
		<title><![CDATA[Difficulty Selling A Drug?: Find A Top Notch Chinese Name For It First!]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=969921]]></link>
		<description><![CDATA[Powerful brand names for pharmaceutical products are important tools to offset competitive pressure from generics and to build customer loyalty. Brand naming for a pharmaceutical product is unique, as it is not only affected by marketing decisions, but also heavily regulated by state legislations. From a marketing perspective, brand naming...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Sat, 10 May 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/brand.html"><![CDATA[Brand]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/branding.html"><![CDATA[Branding]]></category>
		<category domain="http://resources.bnet.com/topic/marketing+research.html"><![CDATA[Marketing Research]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
	</item>
	<item>
		<title><![CDATA[Man Bites Dog: Former Merck CEO Blasts High Drug Prices]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/100058/man-bites-dog-former-merck-ceo-blasts-high-drug-prices/]]></link>
		<description><![CDATA[Most pharmaceutical companies insist that high drug prices are a natural consequence of the risky business of drug discovery, and that huge profits on marketed drugs are necessary to cover the costs of the 5,000 to 10,000 experimental drugs that fail for every one that succeeds. In fact, there are...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 05 May 2008 01:59:08 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/david+p.+hamilton.html"><![CDATA[David P. Hamilton]]></category>
		<category domain="http://resources.bnet.com/topic/dr..html"><![CDATA[Dr.]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/pricing.html"><![CDATA[Pricing]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">MRK</category>
	</item>
	<item>
		<title><![CDATA[More Internet Marketing Looms in Pharma's Future]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/100049/more-internet-marketing-looms-in-pharmas-future/]]></link>
		<description><![CDATA[    By some reports, direct-to-consumer DTC drug advertising is beginning to stagnate -- a trend suggested by Sepracor's recent decision to cut back on TV spots involving its Lunesta moth. Stepping into the breach: More direct-marketing advertising, particularly involving the Internet.    According to a...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 25 Apr 2008 14:56:02 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/direct+marketing.html"><![CDATA[Direct Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/internet+marketing.html"><![CDATA[Internet Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/dma.html"><![CDATA[DMA]]></category>
		<category domain="http://resources.bnet.com/topic/internet.html"><![CDATA[Internet]]></category>
		<category domain="http://resources.bnet.com/topic/sales+channel.html"><![CDATA[Sales Channel]]></category>
		<category domain="http://resources.bnet.com/topic/advertising+%2526+promotion.html"><![CDATA[Advertising & Promotion]]></category>
		<category domain="http://resources.bnet.com/topic/marketing+research.html"><![CDATA[Marketing Research]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/david+p.+hamilton.html"><![CDATA[David P. Hamilton]]></category>
	</item>
	<item>
		<title><![CDATA[Guerrilla Marketing, Pharma Style]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/100035/guerrilla-marketing-pharma-style/]]></link>
		<description><![CDATA[The pharma blogosphere is buzzing about what appears to be a new "guerilla marketing" campaign for the over-the-counter allergy drug Zyrtec.    According to one blogger in Boston and another in New York, many of these seemingly handwritten flyers have been seen taped to telephone poles, scaffolds and...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 21 Apr 2008 17:40:27 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/advertisement.html"><![CDATA[Advertisement]]></category>
		<category domain="http://resources.bnet.com/topic/phone.html"><![CDATA[Phone]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/allergy.html"><![CDATA[Allergy]]></category>
		<category domain="http://resources.bnet.com/topic/phone+number.html"><![CDATA[Phone Number]]></category>
		<category domain="http://resources.bnet.com/topic/telecom+%2526+utilities.html"><![CDATA[Telecom & Utilities]]></category>
		<category domain="http://resources.bnet.com/topic/david+p.+hamilton.html"><![CDATA[David P. Hamilton]]></category>
	</item>
	<item>
		<title><![CDATA[Data Mining In Pharmaceutical Marketing And Sales Analysis]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=328492]]></link>
		<description><![CDATA[This presentation explains the data mining in pharmaceutical marketing and sales analysis. ]]></description>
		<s:doctype><![CDATA[Presentations]]></s:doctype>
		<pubDate>Mon, 18 Jun 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/north+carolina+state+university.html"><![CDATA[North Carolina State University]]></category>
		<category domain="http://resources.bnet.com/topic/data+mining.html"><![CDATA[Data Mining]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/business+intelligence.html"><![CDATA[Business Intelligence]]></category>
		<category domain="http://resources.bnet.com/topic/marketing+research.html"><![CDATA[Marketing Research]]></category>
		<category domain="http://resources.bnet.com/topic/databases.html"><![CDATA[Databases]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/data+management.html"><![CDATA[Data Management]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
	</item>
	<item>
		<title><![CDATA[What you missed.(pharmaceutical industry lobbying against laws on direct to consumer advertising of drugs)(Staples Inc. retains MediaCom as advertising agency)(Federal Trade Commission praises entertainment industry for limiting marketing of violent movie]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6398/is_200704/ai_n25580944]]></link>
		<description><![CDATA[It's high noon on Capitol Hill. The congressional debate over  direct-to-consumer drug advertising is due to kick off Wednesday and ad  and pharmaceutical groups are increasing their lobbying efforts,  desperately hoping to deflect the attack against a   It's high noon on Capitol Hill. The congressional...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 16 Apr 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/advertisement.html"><![CDATA[advertisement]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/entertainment.html"><![CDATA[entertainment]]></category>
		<category domain="http://resources.bnet.com/topic/ftc.html"><![CDATA[FTC]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[marketing]]></category>
		<category domain="http://resources.bnet.com/topic/movie.html"><![CDATA[movie]]></category>
		<category domain="http://resources.bnet.com/topic/staples+inc..html"><![CDATA[Staples Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SPLS</category>
		<category domain="tickers">SPLS</category>
	</item>
	<item>
		<title><![CDATA[EPIX Pharmaceuticals Retains Full Rights to Fibrin-Binding Imaging Agent EP-2104R as Schering AG Decides Not to Exercise Option for Development Program; Company To Seek Development and Marketing Partner for EP-2104R]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_July_13/ai_n26923734]]></link>
		<description><![CDATA[CAMBRIDGE, Mass. -- EPIX Pharmaceuticals, Inc. (NASDAQ: EPIX), a developer of innovative pharmaceuticals for magnetic resonance imaging MRI which recently announced a definitive agreement to merge with Predix Pharmaceuticals Holdings, Inc., today announced that Schering AG, which is undergoing a merger with Bayer AG, is not going to exercise its...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 13 Jul 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[marketing]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Valuing R&D Projects In A Portfolio: Evidence From The Pharmaceutical Industry]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=321671]]></link>
		<description><![CDATA[Understanding the value of a product development project is central to a firm's choice of project portfolio. This is due to interactions with other projects in the portfolio that address the same consumer need and with other projects that require the same development resources. This paper empirically investigates the structure...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Sat, 01 Jul 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/portfolio.html"><![CDATA[Portfolio]]></category>
		<category domain="http://resources.bnet.com/topic/product+development.html"><![CDATA[Product Development]]></category>
		<category domain="http://resources.bnet.com/topic/product+marketing.html"><![CDATA[Product Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/r%2526d.html"><![CDATA[R&D]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/university+of+pennsylvania.html"><![CDATA[University Of Pennsylvania]]></category>
	</item>
	<item>
		<title><![CDATA[European Pharmaceutical Manufacturers Deploy Novel Multi-Country Marketing Initiatives Driven by New Dendrite Marketing Solutions.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5559/is_200602/ai_n23507903]]></link>
		<description><![CDATA[BEDMINSTER, N.J., Feb 27, 2006 CCNMatthews via COMTEX -- Dendrite  International, Inc. (NASDAQ: DRTE) today announced the early European  adoption of one of its strategic Marketing Solutions' offerings,  Physician ConnectTM. The company signed eleve  BEDMINSTER, N.J., Feb 27, 2006 CCNMatthews via COMTEX -- Dendrite  International,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 27 Feb 2006 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/dendrite+international+inc..html"><![CDATA[Dendrite International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[marketing]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/physician.html"><![CDATA[physician]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
</channel>
</rss>
